SCHEMBL11203237

SCHEMBL11203237

COC(=O)OC1=C(C)NC(C)=C(OC(=O)OC(C)C)C1c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1C Q13936 2/20 0.48
CACNA1F O60840 1/20 0.48
CACNA1D Q01668 1/20 0.48
CACNA1S Q13698 1/20 0.48
ADORA3 P0DMS8 2/20 0.46
KDM4E B2RXH2 5/20 0.40
PYGM P11217 2/20 0.39
PYGL P06737 1/20 0.39
ALDH1A1 P00352 4/20 0.39
KMT2A Q03164 4/20 0.39
HSD17B10 Q99714 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
MAPT P10636 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
CYP1A2 P05177 4/20 0.38
CYP3A4 P08684 4/20 0.38
CYP2C9 P11712 4/20 0.38
CYP2C19 P33261 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10920209 0.96 CACNA1F (0.45) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL10786897 0.92 ADORA3 (0.52) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL9691613 0.88 ADORA3 (0.49) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL10923715 0.87 CACNA1F (0.44) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL11363163 0.86 GAA (0.48) KDM4EALDH1A1KMT2AHSD17B10SMN1; SMN2
SCHEMBL9689715 0.85 ADORA3 (0.49) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL9689619 0.83 ADORA3 (0.47) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL10643307 0.82 MEN1 (0.61) CACNA1CCACNA1FCACNA1DCACNA1SADORA3
SCHEMBL11372181 0.82 KDM4E (0.57) CACNA1CADORA3KDM4EALDH1A1KMT2A
SCHEMBL11366080 0.81 CACNA1C (0.38) CACNA1CCACNA1FCACNA1DCACNA1SADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0088938-A1 Use of pyridine compounds for the manufacture of medicaments with an antihypoxemia and ischemia-protective activity BAYER AG (DE) 1983-09-21 EP disclosed